Evidence map›Paper›PMID 38245747›Full record

ArticleInfectious agents and cancer2024

The causality between CD8

Zhengmei Lu, Xiaowei Chai, Yong Pan, Shibo Li

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Zhengmei LuDepartment of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, 316021, China.
Xiaowei ChaiTongji Hospital Affiliated to Tongji University, Shanghai, 200040, China.
Yong PanDepartment of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, 316021, China.
Shibo LiDepartment of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, 316021, China. lsb0398@126.com.
Wenzhou Medical University · CNTongji Hospital · CNZhoushan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC), which is featured with high morbidity and mortality worldwide, is a primary malignant tumor of the liver. Recently, there is a wealth of supporting evidence revealing that NK cell-related immune traits are strongly associated with the development of HCC, but the causality between them has not been proven.

methodsTwo-sample Mendelian randomization (MR) study was performed to probe the causal correlation between NK cell-related immune traits and HCC. Genetic variations in NK cell-related immune traits were extracted from recent genome-wide association studies (GWAS) of individuals with European blood lineage. HCC data were derived from the UK Biobank Consortium's GWAS summary count data, including a total of 372,184 female and male subjects, with 168 cases and 372,016 controls, all of whom are of European ancestry. Sensitivity analysis was mainly used for heterogeneity and pleiotropy testing.

resultsOur research indicated the causality between NK cell-related immune traits and HCC. Importantly, CD8

conclusionMR analysis suggested that low CD8

Indexed as

CD16−CD56 on NK cellsCD8+NKT cellsHepatocellular carcinoma (HCC)Mendelian randomization (MR)

Identifiers

PMID38245747
PMCPMC10799464
OpenAlexW4391053621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.